88 related articles for article (PubMed ID: 9013748)
1. Serum immunoreactive-leptin levels are increased in patients with Cushing's syndrome.
Leal-Cerro A; Considine RV; Peino R; Venegas E; Astorga R; Casanueva FF; Dieguez C
Horm Metab Res; 1996 Dec; 28(12):711-3. PubMed ID: 9013748
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
3. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
[TBL] [Abstract][Full Text] [Related]
4. 24-hour serum concentration profile of cortisol in patients with Cushing's disease.
Pirich K; Vierhapper H
Exp Clin Endocrinol; 1988 Mar; 92(3):275-9. PubMed ID: 2855318
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
Ambrosi B; Sartorio A; Pizzocaro A; Passini E; Bottasso B; Federici A
Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361
[TBL] [Abstract][Full Text] [Related]
6. Salivary cortisol measurement--a reliable method for the diagnosis of Cushing's syndrome.
Trilck M; Flitsch J; Lüdecke DK; Jung R; Petersenn S
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):225-30. PubMed ID: 15891959
[TBL] [Abstract][Full Text] [Related]
7. Determinants of serum leptin levels in Cushing's syndrome.
Widjaja A; Schürmeyer TH; Von zur Mühlen A; Brabant G
J Clin Endocrinol Metab; 1998 Feb; 83(2):600-3. PubMed ID: 9467580
[TBL] [Abstract][Full Text] [Related]
8. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
9. Circadian pattern of serum androgens in women with Cushing's syndrome.
Kreze A; Mikulecky M; Putz Z; Moravcik M
Acta Med Hung; 1992-1993; 49(3-4):171-8. PubMed ID: 1345454
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin and adiponectin in patients with Cushing's disease before and after successful transsphenoidal surgery.
Libè R; Morpurgo PS; Cappiello V; Maffini A; Bondioni S; Locatelli M; Zavanone M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Jan; 62(1):30-6. PubMed ID: 15638867
[TBL] [Abstract][Full Text] [Related]
11. Thyroid axis in patients with Cushing's syndrome.
Duick DS; Wahner HW
Arch Intern Med; 1979 Jul; 139(7):767-72. PubMed ID: 110278
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome.
Masuzaki H; Ogawa Y; Hosoda K; Miyawaki T; Hanaoka I; Hiraoka J; Yasuno A; Nishimura H; Yoshimasa Y; Nishi S; Nakao K
J Clin Endocrinol Metab; 1997 Aug; 82(8):2542-7. PubMed ID: 9253331
[TBL] [Abstract][Full Text] [Related]
13. [The effects of glucocorticoids and insulin on serum leptin level and its diurnal rhythmicity].
Wang Q; Chen M; Hu R; Tang J; Li F; Luo B
Zhonghua Nei Ke Za Zhi; 2002 Feb; 41(2):104-8. PubMed ID: 11940306
[TBL] [Abstract][Full Text] [Related]
14. Markers of vascular function in hypertension due to Cushing's syndrome.
Zacharieva S; Atanassova I; Nachev E; Orbetzova M; Kirilov G; Kalinov K; Shigarminova R
Horm Metab Res; 2005 Jan; 37(1):36-9. PubMed ID: 15702437
[TBL] [Abstract][Full Text] [Related]
15. [The rhythmicity of adiponectin and its relation with glucocorticoids, insulin and leptin].
Yang Y; Tang JF; Wang QD; Li FY; Zhang YB; Zhou LB; Chen MD
Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):515-8. PubMed ID: 15312406
[TBL] [Abstract][Full Text] [Related]
16. [Plasma leptin levels in relation to body composition and body fat distribution in patients with Cushing's syndrome].
Robaczyk M; Krzyzanowiska-Swiniarska B; Andrysiak-Mamos E; Kulig G; Pilarska K
Pol Arch Med Wewn; 2003 Nov; 110(5):1299-308. PubMed ID: 16737000
[TBL] [Abstract][Full Text] [Related]
17. Leptin levels in relation to body composition and insulin concentration in patients with endogenous Cushing's syndrome compared to controls matched for body mass index.
Schafroth U; Godang K; Ueland T; Berg JP; Bollerslev J
J Endocrinol Invest; 2000 Jun; 23(6):349-55. PubMed ID: 10908161
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study.
Ueland T; Kristo C; Godang K; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2003 Apr; 88(4):1492-6. PubMed ID: 12679428
[TBL] [Abstract][Full Text] [Related]
19. Increased Adipocyte Size, Macrophage Infiltration, and Adverse Local Adipokine Profile in Perirenal Fat in Cushing's Syndrome.
Roerink SHPP; Wagenmakers MAEM; Langenhuijsen JF; Ballak DB; Rooijackers HMM; d'Ancona FC; van Dielen FM; Smit JWA; Plantinga TS; Netea-Maier RT; Hermus ARMM
Obesity (Silver Spring); 2017 Aug; 25(8):1369-1374. PubMed ID: 28594137
[TBL] [Abstract][Full Text] [Related]
20. Influence of cortisol status on leptin secretion.
Leal-Cerro A; Soto A; Martínez MA; Dieguez C; Casanueva FF
Pituitary; 2001; 4(1-2):111-6. PubMed ID: 11824503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
